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Objectives:  Connective  tissue  diseases  involve  characteristic  inﬂammatory  lesions  in  the  car-
diovascular  system,  in  addition  to  other  systems.  The  involvement  of  the  cardiovascular  system
in the  course  of  connective  tissue  diseases  may  result  in  serious  morbidity  and  mortality.
Pulse wave  velocity  which  is  an  indicator  of  arterial  dilatation  capacity  may  predict  car-
diovascular  risk  of  patients.  Pulse  wave  velocity  is  inversely  proportional  to  arterial  dilatation
capacity.  Decreased  dilatation  capacity  leads  to  a  reduction  in  arterial  blood  pressure  and  ﬂow
dynamics and  impairment  in  coronary  perfusion.
Methods:  In  our  study,  we  examined  pulse  wave  velocity  in  frequent  chronic  inﬂam-
matory rheumatologic  diseases:  rheumatoid  arthritis,  systemic  lupus  erythematosus,  and
Behc¸et’s disease.  A  total  of  98  subjects  participated  in  our  study  including  24  patients  with
newly diagnosed  rheumatoid  arthritis  (4  males,  20  females;  mean  age  42.5  ±  11.5  years),  22
patients with  newly  diagnosed  systemic  lupus  erythematosus  (1  male,  21  females;  mean  age
35.8 ±  11.1  years),  33  patients  with  newly  diagnosed  Behc¸et’s  disease  (26  males,  7  females;
mean age  32.7  ±  8.0  years),  and  19  healthy  subjects  in  the  control  group  (10  males,  9  females;
mean age  36.2  ±  15.0  years).  Aorta  pulse  wave  velocity  was  determined  by  Complior  Colson  (Cre-
atech Industrie,  Garges  les  Gonesses,  France)  device  which  allowed  for  pulse  wave  recording
and automated  measurement.
Results:  Pulse  wave  velocity  was  higher  in  rheumatoid  arthritis,  systemic  lupus  erythematosus,
and Behc¸et’s  disease  groups  compared  to  the  control  group.  When  all  variables  were  included
in the  regression  analysis  only  age  was  found  to  affect  pulse  wave  velocity  independently.
Conclusion:  Pulse  wave  velocity
diseases compared  to  the  contr
Age was  determined  as  the  mos
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eEvaluation  of  arterial  dilatation  capacity  
Introduction
Connective  tissue  diseases  involve  characteristic  inﬂamma-
tory  lesions  in  the  cardiovascular  system,  in  addition  to  other
systems.  The  involvement  of  the  cardiovascular  system  in
the  course  of  connective  tissue  diseases  may  result  in  serious
morbidity  and  mortality  [1—3].
Arteriosclerosis  develops  in  the  process  of  cardiovascular
aging  while  several  rheumatologic  diseases  accelerate  this
process  [4].
Invasive  or  non-invasive  methods  are  used  for  arte-
riosclerosis.  Non-invasive  methods  which  are  preferred  for
being  simple  and  their  ease  of  use  include  hysteresis
of  pressure—diameter  curves,  arterial  diameter  wave-
form,  arterial  pressure  waveform,  arterial  wall  thickness,
viscoelastic  parameters,  relative  arterial  compliance  cal-
culated  by  classical  formula  of  Bramwell  and  Hill  [volume
change  (dV)  ratio  induced  by  the  change  in  transmural  ten-
sion  pressure  (dP)  (dV/dP)]  and  pulse  wave  velocity  (PWV)
measurement  [5—7].
Arterial  stiffness  is  increasingly  recognized  as  a  surro-
gate  end  point  for  cardiovascular  disease.  The  measurement
of  aortic  PWV,  which  is  considered  the  gold  standard
method  for  assessing  aortic  stiffness,  is  a  tool  for  assess-
ment  of  subclinical  organ  damage  [8].  Measurement  of
PWV  is  one  of  the  major  methods  to  determine  the  elas-
ticity  of  large  vessels  and  is  based  on  the  measurement
principal  using  two  ultrasound  or  pressure  sensitive  trans-
ducers  placed  on  the  skin  above  traces  of  two  arteries  in
a  speciﬁc  distance  (carotid—femoral  arteries  are  used  in
our  study)  [5].  Measured  PWV  is  an  indicator  of  arterial
wall  stiffness  and  also  inversely  proportional  to  arterial
dilatation  capacity  or  arterial  compliance  [2].  Similar  to
arterial  elasticity,  PWV  and  arterial  dilatation  capacity
index  are  also  affected  by  heart  rate  and  blood  pres-
sure  [6].  Pulse  pressure  and  PWV  are  supported  in  studies
in  which  they  are  predictors  of  cardiovascular  diseases
in  the  general  population  and  in  patients  with  hyperten-
sion,  diabetes,  advanced  age,  and  end  stage  renal  failure
[7—14].
Systemic  lupus  erythematosus  (SLE)  is  a  disease  charac-
terized  by  generalized  inﬂammation  of  connective  tissues
and  vessel  structures  particularly  in  young  women.  This
systemic  disease  is  associated  with  hypertension  [15],
myocardial  infarction  [15,16],  and  risk  of  stroke.  While
the  pathogenesis  of  vascular  disease  in  SLE  is  not  clearly
understood,  it  is  considered  to  be  multifactorial  and  that
atherosclerotic  factors  have  a  role  [17].
Behc¸et’s  disease  (BD)  is  a  diffuse  vasculitic  disease  char-
acterized  by  repeated  genital  and  oral  ulcerations  and
uveitis.  Dilatation  developed  in  proximal  aorta  as  a  result
of  diffuse  aortitis  may  cause  severe  aorta  failure  requiring
valve  replacement  [18]. Deep  vein  and  arterial  thrombosis,
and  aortic  and  arterial  aneurysm  may  occur  in  the  course  of
disease.
Rheumatoid  arthritis  (RA)  is  a  systemic  inﬂammatory
disease  associated  with  accelerated  atherosclerosis  and  con-
sequently  increased  cardiovascular  mortality  and  morbidity
[19].  This  inﬂammation  results  in  endothelial  dysfunction.
The  changes  in  arterial  compliance  and  elasticity  have






rterial  pulse  wave  velocity
urrently,  cardiovascular  diseases  are  important  causes  of
ortality.  It  is  not  clearly  understood  how  atherosclero-
is  begins  and  progresses  in  large  arteries.  Because  the
therosclerosis  process  and  most  cardiovascular  risk  factors
re  insidious,  the  early  diagnosis  of  arterial  changes  and
unctional  and/or  structural  lesions  will  be  useful  in  identify-
ng  individuals  under  high  risk  for  clinical  events.  Conducting
ynamic  studies  on  large  arteries  is  difﬁcult  because  blood
ow  is  pulsatile  in  nature;  vessel  wall  has  a complex  struc-
ure  and  the  tonus  of  the  smooth  muscle  component  differs
ontinuously  [20]. PWV  was  developed  to  evaluate  the  vis-
oelasticity  of  large  vessels  in  human.
The  measurement  of  PWV  is  one  of  the  important  meth-
ds  to  identify  the  elasticity  properties  of  arteries.  It  is
ased  on  the  measurement  principal  using  two  ultrasound
r  pressure  sensitive  transducers  placed  on  the  skin  above
he  traces  of  two  arteries  in  a  speciﬁc  distance  (such  as
arotid—femoral,  brachial—radial  arteries)  [5].  Measured
WV  is  an  indicator  of  arterial  wall  stiffness  and  also
nversely  proportional  to  arterial  dilatation  capacity  (dilata-
ion  capacity)  or  relative  arterial  elasticity  (elasticity)  [6].
dditionally,  aortic  PWV  is  a  strong  predictor  of  future  car-
iovascular  events  and  all-cause  mortality  [8].
Age  and  atherosclerosis  show  more  signiﬁcant  impact
n  central  and  elastic  arteries.  In  both  genders,  the
elocity  levels  of  aorta  pulse  wave  (carotid—femoral  or
ody  PWV)  increase  with  age.  The  studies  using  non-
nterventional  techniques  based  on  pressure  waves  or  blood
ow  rate  showed  that  advancing  age  increases  the  aorta  or
arotid—femoral  PWV  [21,22].  A  study  was  conducted  in  a
hinese  population  who  are  known  to  have  a  low  prevalence
f  atherosclerosis,  to  analyze  the  effect  of  age  on  arterial
tiffness  [21]. According  to  this  study,  the  values  for  central
WV  were  lower  than  the  values  of  peripheral  PWV.
The  objective  of  this  study  was  to  evaluate  arterial
ilatation  capacity  by  carotid—femoral  PWV  in  newly  diag-
osed  SLE,  RA,  and  BD  and  to  determine  the  relationship
etween  them  for  arterial  dilatation  capacity.
aterials and methods
 total  of  98  subjects  participated  in  our  study  includ-
ng  24  patients  with  newly  diagnosed  RA  (4  males,  20
emales;  mean  age  42.5  ±  11.5  years),  22  patients  with
ewly  diagnosed  SLE  (1  male,  21  females;  mean  age
5.8  ±  11.1  years),  33  patients  with  newly  diagnosed  BD  (26
ales,  7  females;  mean  age  32.7  ±  8.0  years),  and  19  healthy
ubjects  in  the  control  group  (10  males,  9  females;  mean
ge  36.2  ±  15.0  years).  Written  consent  was  obtained  from
ll  participants.
Patients  with  secondary  or  treatment-resistant  hyper-
ension,  diabetes,  hyperlipidemia  (total  cholesterol  levels
200  mg/dL),  heart  failure,  renal  failure  (plasma  creatinine
1.5  mg/dL),  hepatic  failure,  heart  valve  disease,  periph-
ral  vessel  disease,  cerebrovascular  disease,  and  previous
yocardial  infarction  anamnesis,  identiﬁed  to  have  atrial
brillation  and/or  previous  myocardial  infarction  ﬁndings
n  12-lead  surface  electrocardiography,  smokers,  and  in























































































easons  patients  having  body  mass  index  of  ≥35  kg/m2 and
aist  to  hip  ratio  of  ≥1  were  excluded  from  the  study.
atients  having  active  diseases  and  using  immunosuppres-
ant  agents  (steroid,  azothioprine,  methotrexate,  and
yclophosphamide)  were  not  included  in  the  study.
easurements
he  weight  and  height  of  participants  with  light  clothing  and
are  feet  were  measured  using  standard  scales  with  mobile
uler  marker  and  an  arm  capable  of  weight  measurement.
ody  mass  index  (kg/m2)  was  calculated  by  dividing  weight
n  kg  to  height  in  m2.
Waist  circumference  (cm)  was  measured  at  the  middle
ine  between  last  rib  and  crista  iliac  after  ensuring  the  par-
icipant  was  standing  straight,  relaxed  abdomen  with  arms
own  and  feet  closed.  Hip  circumference  (cm)  was  measured
t  the  line  of  trochanter  major.  Waist—hip  ratio  was  calcu-
ated  by  dividing  waist  circumference  to  hip  circumference.
Arterial  blood  pressure  was  measured  with  a  standard
ercury  monometer  (ERKA,  Bad  Tölz,  Germany)  in  the  lying
osition  after  30  min  of  rest.  Systolic  blood  pressure  was
onsidered  as  the  point  in  which  Korotkoff  sounds  were  ﬁrst
eard;  diastolic  blood  pressure  was  considered  as  the  point
hat  the  sounds  disappear  (phase  5).
The  following  formulations  were  used:
ulse  pressure
=  systolic  blood  pressure  −  diastolic  blood  pressure
ean  blood  pressure
= systolic  blood  pressure  +  2  ×  diastolic  blood  pressure
3
Heart  rate  was  determined  by  counting  for  1  min  after
he  blood  pressure  measurement  from  radial  artery.
easurement  of  carotid—femoral  pulse  wave
elocity
orta  PWV  was  calculated  as  mentioned  above,  using
omplior  device  (Createch  Industrie,  Garges  les  Gonesses,
rance)  which  allows  for  automated  pulse  wave  recording
nd  automated  calculation  of  PWV  [23]. The  correlation
oefﬁcient  of  automated  measurement  method  for  inter-
bserver  measurements  and  for  measurements  between
ifferent  time  points  by  one  observer  was  >0.9.  Carotid
ommunis  and  femoral  arterial  pressure  waveforms  were
easured  non-invasively  by  using  TY-306  Fukuda  (Fukuda,
okyo,  Japan)  pressure  sensitive  transducer.  Measurements
ere  repeated  in  cardiac  cycle  for  more  than  10  phases
nd  mean  value  was  used  for  analyses  of  results.  PWV  was




D  is  the  distance  between  two  recording  points  taken  by
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ransition  time  automatically  determined  by  Complior
evice  (s).
tatistical  evaluation
tatistical  analysis  was  conducted  by  using  IBM  SPSS  ver-
ion  13.0  ready  to  use  statistical  program  (IBM,  Armonk,
Y,  USA).  Inter-group  comparisons  were  conducted  by  using
ne-way  ANOVA  and  post  hoc  Tukey  test.  Regression  analysis
ethod  was  used  for  independent  variables  that  may  affect
WV.  Results  were  expressed  as  mean  ±  standard  deviation.
tatistical  signiﬁcance  was  p  <  0.05.
esults
 total  of  98  subjects  participated  in  our  study  including  24
atients  with  newly  diagnosed  RA,  22  patients  with  newly
iagnosed  SLE,  33  patients  with  newly  diagnosed  BD,  and  19
ealthy  subjects  in  the  control  group.
The  mean  values  of  connective  tissue  diseases  of  SLE,
A,  BD,  and  the  control  group  are  presented  in  Table  1.
he  inter-group  analyses  with  one-way  ANOVA  and  post  hoc
ukey  test  showed  statistical  signiﬁcance  only  between  age
p  =  0.01)  and  PWV  (p  =  0.007).  No  signiﬁcance  was  deter-
ined  in  the  inter-group  analyses  for  body  mass  index,
aist—hip  ratio,  systolic  blood  pressure,  diastolic  blood
ressure,  mean  blood  pressure  and  pulse  pressure,  and  heart
ate  (p  <  0.05).
According  to  age  groups  in  which  signiﬁcance  was  deter-
ined,  age  was  higher  in  the  RA  group  compared  to  the  BD
roup  (p  =  0.009).  There  was  no  signiﬁcant  difference  for  age
etween  the  control  group  and  connective  tissue  diseases
p  >  0.05).
PWV  was  higher  in  SLE,  BD,  and  RA  groups  compared
o  the  control  group  (respectively,  p  =  0.019;  p  =  0.012;
 =  0.018).
egression  analysis
hen  all  variables  were  included  in  the  regression  analysis
R  =  0.51;  R2 =  0.26;  p  =  0.001;  F  =  3.563)  only  age  was  found
o  affect  PWV  independently  (p  <  0.001;  t  =  3.903).  No  signif-
cance  was  determined  for  gender  (p  =  0.86).  The  correlation
f  PWV  as  an  independent  variable  with  other  parameters  is
iven  in  Table  2.
iscussion
e  evaluated  the  PWV  by  using  carotid—femoral  PWV  in
onnective  tissue  diseases  concurrent  with  chronic  inﬂam-
atory  processes  such  as  RA,  SLE,  and  BD  in  our  study.
n  increase  in  carotid—femoral  PWV  was  determined  in  all
atients  who  participated  in  our  study  compared  to  the  con-
rol  group.
Connective  tissue  diseases  are  mainly  considered  as  dis-
ases  of  the  musculoskeletal  system,  while  they  can  involve
he  cardiovascular  system,  characterized  by  inﬂammatory
esions.  Generally,  the  most  important  cause  of  mortality
nd  morbidity  in  connective  tissue  diseases  is  cardiovascular
nvolvement  [1,4,19].
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Table  1  Mean  values  of  the  parameters  of  systemic  lupus  erythematosus  (SLE),  Behc¸et’s  disease  (BD),  and  rheumatoid  arthritis
(RA) and  control  group.
Control  group  SLE  group  BD  group  RA  group
Age* 36.2  ±  15.0  35.8  ±  11.1  32.7  ±  8.0  42.5  ±  11.5
Waist—hip ratio  0.86  ±  0.0  0.83  ±  0.0  0.85  ±  0.0  0.83  ±  0.0
Systolic blood  pressure 111.05  ±  11.50  121.14  ±  14.47  114.39  ±  12.48  118.33  ±  12.39
Diastolic blood  pressure 71.05 ±  7.37  72.64 ±  8.76  72.58 ±  10.39  76.46  ±  7.87
Heart rate 74.53 ±  9.01  77.95 ±  5.96  75.24 ±  7.08  76.75 ±  8.29
Pulse wave  velocity** 7.53 ±  0.80  9.29 ±  2.46  9.23 ±  1.64  9.26 ±  2.16
Body mass  index  25.89  ±  3.88  25.90  ±  4.72  24.36  ±  3.03  25.75  ±  3.73
Pulse pressure  41.57  ±  11.18  48.50  ±  11.91  36.39  ±  10.57  41.87  ±  11.49
Mean blood  pressure  84.89  ±  7.47  88.77  ±  9.47  71.81  ±  7.78  90.45  ±  7.87
























PThe inter-group analyses with one-way ANOVA and post hoc T
groups compared to control group (respectively, p = 0.019; p = 0.01
The  importance  of  cardiovascular  diseases  in  rheumato-
logic  diseases  became  signiﬁcant  as  a  result  of  prolonged  life
time  with  the  improvements  in  the  treatment  of  rheuma-
tologic  diseases,  the  recognition  of  the  importance  of
inﬂammation,  the  better  understanding  of  the  impact  of
the  immune  system  on  atherosclerosis,  and  the  usage  of
improved  non-invasive  diagnostic  methods  for  cardiovascu-
lar  diseases.
Inﬂammation  causes  endothelial  dysfunction  and
atherosclerosis.  Endothelial  dysfunction  characterized  by
decreased  nitric  oxide  bioavailability  comprises  the  early
stage  of  atherosclerosis  [22]. Inﬂammation,  which  is  the
basis  for  atherosclerosis,  and  the  damage  in  vessel  walls
lead  to  an  increase  in  arterial  stiffness.  Atherosclerosis  and
its  impacts  on  vessels  can  be  identiﬁed  by  non-invasive
techniques  [23]. One  of  these  techniques  is  the  measure-
ment  of  PWV  which  is  an  indicator  for  arterial  dilatation
capacity  and  deﬁned  as  the  velocity  of  arterial  wave
through  the  vessel  [22,23].  The  patients  who  have  an
increased  cardiovascular  and  cerebrovascular  risk  can  be
determined  by  PWV  [23]. PWV  is  an  indicator  of  arterial
wall  stiffness  and  also  inversely  proportional  to  arterial
dilatation  capacity  (dilatation)  or  relative  arterial  elasticity
(elasticity)  [6].
Several  biochemical  markers  have  been  used  to  examine
different  aspects  of  endothelial  cell  functions  such  asym-
metrical  dimethylarginine,  soluble  intercellular  adhesion
Table  2  The  correlation  of  pulse  wave  velocity  with  other
parameters.
Pulse  wave  velocity  p
Age  <0.001
Waist—hip  ratio  0.46
Systolic  blood  pressure  0.05
Diastolic  blood  pressure  0.57
Heart rate  0.94
Body mass  index 0.48
Pulse  pressure  0.86















ttest showed: pulse wave velocity was higher in SLE, BD, and RA
= 0.018).
olecule-1,  soluble  vascular  cell  adhesion  molecule,  plas-
inogen  activator  inhibitor-I,  and  tissue  plasminogen
ctivator.  Although  the  ability  of  these  parameters  to  detect
ndothelial  dysfunction  before  overt  cardiovascular  disease
ake  them  attractive  tools,  determination  of  these  param-
ters  is  not  easy  and  cost-effective  [24].
heumatoid  arthritis
e  found  that  carotid—femoral  PWV  was  increased  in  the
A  group,  the  prototype  of  systemic  inﬂammatory  diseases
n  which  accelerated  atherosclerosis  and  increased  car-
iovascular  mortality  and  morbidity  is  present,  compared
o  the  control  group  (9.26  ±  2.16  m/s  vs.  7.53  ±  0.80  m/s,
 =  0.018).  This  ﬁnding  is  consistent  with  other  studies
22,25,26]. The  inﬂammation  produced  in  the  course  of
A  impairs  endothelial  function  and  plays  an  important
ole  in  the  initiation  and  progression  of  atherosclerosis.
arotid—femoral  PWV,  which  is  an  important  indicator  of
nﬂammation,  is  increased  during  this  process.  Arterial  stiff-
ess  is  associated  with  the  duration  of  the  disease  and
nﬂammatory  mediators  [27]. In  this  study,  the  increased
WV  of  patients  with  newly  diagnosed  RA  shows  that  inﬂam-
ation  has  previously  affected  endothelium.
Endothelial  dysfunction  has  been  implicated  as  an  impor-
ant  event  in  the  pathogenesis  of  arteriosclerosis,  coronary
asoconstriction,  hypertension,  and  myocardial  ischemia
specially  during  connective  tissue  diseases.  Ghelani  et  al.
28]  reported  that  during  Kawasaki  disease  without  overt
oronary  artery  involvement,  there  are  signiﬁcant  differ-
nces  for  the  percent  ﬂow  mediated  dilatation  and  carotid
rtery  stiffness  index  between  children  with  Kawasaki  dis-
ase  and  controls.  Another  report  from  Hamaoka  et  al.  [29]
howed  that  ﬂuvastatin  treatment  changed  the  PWV.  There
as  a  signiﬁcant  decrease  after  12  months  of  treatment.
ystemic  lupus  erythematosusnﬂammation  was  shown  to  be  positively  correlated  with
therosclerosis  in  SLE,  which  is  a  chronic  inﬂamma-




























































articularly  in  young  women  [30]. We  found  that
arotid—femoral  PWV  was  increased  in  the  22  patients  with
LE  who  participated  in  our  study,  compared  to  19  control
ubjects  (9.29  ±  2.46  m/s  vs.  7.53  ±  0.80  m/s,  p  =  0.019).
he  study  conducted  by  Yildiz  et  al.  [31]  showed  that
rterial  dilatation  capacity  was  decreased  in  female  post-
enopausal  patients  with  SLE.  In  our  study,  the  increased
WV  of  patients  with  newly  diagnosed  SLE  shows  that  inﬂam-
ation  has  affected  endothelium  before  musculoskeletal
ystem,  similar  to  RA.
ehc¸et’s  disease
he  reason  for  vascular  involvement  in  BD,  which  appears
ith  oral  aphthous  and  genital  ulcers,  skin  lesions,  and
veitis,  is  considered  to  be  vasculitis.  We  compared  33
atients  with  BD  with  a  control  group  including  19  healthy
ubjects  in  our  study.  Carotid—femoral  PWV  increased  sig-
iﬁcantly  in  the  BD  group  compared  to  the  control  group
9.23  ±  1.64  m/s  vs.  7.53  ±  0.80  m/s,  p  =  0.012).  This  ﬁnd-
ng  is  supported  with  the  results  of  the  study  by  Chang
t  al.  [32], but  in  another  study,  it  was  reported  that  there
as  no  difference  between  BD  and  control  group  for  PWV
33].  A  study  conducted  by  Kurum  et  al.  [33]  included  14
atients  with  BD  and  showed  no  difference  with  healthy  con-
rol  group  for  PWV.  This  may  be  due  to  the  small  number  of
atients  who  participated  in  the  study.  Our  study  supports
he  hypothesis  that  inﬂammation  seen  in  the  course  of  BD
mpairs  vascular  function  and  increases  arterial  stiffness.
Although  PWV  was  found  to  be  higher  in  connective  tis-
ue  diseases  compared  to  the  control  group,  no  difference
etween  disease  groups  was  determined.  Therefore,  it  may
e  concluded  that  arterial  stiffness  is  increased  equally  in
hronic  inﬂammatory  rheumatologic  diseases.
elation  with  age
n  elder  individuals,  arteries  are  less  elastic  and  velocity
f  pulse  wave  is  high;  reﬂected  wave  can  be  observed  in
scending  arm  of  systolic  pressure.  The  typical  changes
n  the  pattern  of  pulse  wave  with  age  are  attributed  to
ncreased  aorta  stiffness  and  PWV  [23,33,34]. Several  stud-
es  also  showed  that  aorta  PWV  levels  (carotid—femoral  or
ody  PWV)  were  increased  with  age  [21,35].  In  our  study,
lthough  there  was  a  signiﬁcant  difference  only  between
atients  with  BD  and  RA  for  age,  no  difference  was  found
hen  control  groups  were  compared  with  other  groups.  In
he  regression  analysis  of  all  variables,  age  was  found  to  be
he  most  important  independent  variable.  The  detection  of
ncrease  of  PWV  parallel  to  advanced  age  is  supported  by
ther  studies  [36].
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